# Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

> **NCT01579110** · PHASE2 · UNKNOWN · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 100 (estimated)

## Conditions studied

- Anemia
- Anemia, Hemolytic
- Anemia, Hemolytic, Autoimmune
- Hemolysis
- Hematologic Diseases
- Autoimmune Diseases
- Immune System Diseases
- Pathologic Processes

## Interventions

- **DRUG:** levamisole
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT01579110
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579110, "Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01579110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*